Evidence map›Paper›PMID 33077300›Full record

ArticleVaccine2020

Immunization costs, from evidence to policy: Findings from a nationally representative costing study and policy translation effort in Tanzania.

Kelsey Vaughan, Emma Clarke-Deelder, Kassimu Tani, Dafrossa Lyimo, Alex Mphuru, Fatuma Manzi, Carl Schütte, Annette Ozaltin

Abstract read
In one paragraph

Article in Vaccine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kelsey VaughanThinkWell, Washington, DC, USA.
Emma Clarke-DeelderHarvard T.H. Chan School of Public Health, Department of Global Health and Population, Boston, MA, USA. Electronic address: emmaclarke@g.harvard.edu.
Kassimu TaniIfakara Health Institute, Dar es Salaam, Tanzania.
Dafrossa LyimoImmunization and Vaccines Development (IVD), Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
Alex MphuruImmunization and Vaccines Development (IVD), Ministry of Health, Community Development, Gender, Elderly and Children, Dar es Salaam, Tanzania.
Fatuma ManziIfakara Health Institute, Dar es Salaam, Tanzania.
Carl SchütteGenesis Analytics, Johannesburg, South Africa.
Annette OzaltinThinkWell, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInformation on the costs of routine immunization programs is needed for budgeting, planning, and domestic resource mobilization. This information is particularly important for countries such as Tanzania that are preparing to transition out of support from Gavi, the Vaccine Alliance. This study aimed to estimate the total and unit costs for of child immunization in Tanzania from July 2016 to June 2017 and make this evidence available to key stakeholders.

methodsWe used an ingredients-based approach to collect routine immunization cost data from the facility, district, regional, and national levels. We collected data on the cost of vaccines as well as non-vaccine delivery costs. We estimated total and unit costs from a provider perspective for each level and overall, and examined how costs varied by delivery strategy, geographic area, and facility-level service delivery volume. An evidence-to-policy plan identified key opportunities and stakeholders to target to facilitate the use of results.

resultsThe total annual economic cost of the immunization program, inclusive of vaccines, was estimated to be US$138 million (95% CI: 133, 144), or $4.32 ($3.72, $4.98) per dose. The delivery costs made up $45 million (38, 52), or $1.38 (1.06, 1.70) per dose. The costs of facility-based delivery were similar in urban and rural areas, but the costs of outreach delivery were higher in rural areas than in urban areas. The facility-level delivery cost per dose decreased with the facility service delivery volume. DISCUSSION: We estimated the costs of the routine immunization program in Tanzania, where no immunization costing study had been conducted for five years. These estimates can inform the program's budgeting and planning as Tanzania prepares to transition out of Gavi support. Next steps for evidence-to-policy translation have been identified, including technical support requirements for policy advocacy and planning.

Indexed as

VaccinationVaccinesChildHumansImmunization ProgramsPolicyTanzaniaVaccinesCostingExpanded programme on immunizationImmunizationImmunization delivery costsImmunization economicsVaccination

Identifiers

PMID33077300
PMCPMC7604567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.